The N-acetylation of arsanilic acid was assayed in vitro by modifying a lit
erature method for acetylation of p-aminobenzoic acid. Conditions included
final concentrations of 1.0 mM dithiothreitol, 1.0 mM EDTA, 0.45 mM acetyl
coenzyme A, an acetyl coenzyme A regenerating system using bacterial phosph
otransacetylase and acetyl phosphate, 5.0 mM arsanilate substrate, and 25 m
M sodium/potassium phosphate buffer, pH 7.4, in a total volume of 0.5 ml. I
ncubation was at 37 degrees C, with 0.5- to 2-mg N-acetyltransferase enzyme
protein from a preparation of guinea pig liver. The reaction was terminate
d by heat precipitation. The resulting supernatant was put through a 4 mm 0
.45 mu m polysulfone membrane syringe filter. The filtrate could then be in
jected directly onto the HPLC. With arsanilic acid as substrate, the produc
t N-acetylarsanilic acid (NAA) was identified by its retention time (33 min
) in the HPLC system of the laboratory. The 33-min fraction collected from
the HPLC was scanned and gave the characteristic UV spectrum of NAA, with p
eaks at 203 and 256 nm. In addition, the product comigrated in the HPLC sys
tem with standard NAA. Under comparable assay conditions, the N-acetylation
of arsanilate by the guinea pig enzyme preparation is about 24% the rate o
f that of the model substrate p-aminobenzoic acid. Typical activity for ars
anilate acetylation was 0.5 nmol/min/mg enzyme protein. Using the same assa
y system and HPLC detection method, the supernatant from bacterial lysates
containing recombinant human N-acetyltransferase 1 exhibited acetylation ac
tivity toward arsanilate of 720 nmol/min/mg enzyme protein.